Oncotarget

Research Papers:

Visualization of exosome-mediated miR-210 transfer from hypoxic tumor cells

Kyung Oh Jung, Hyewon Youn _, Chul-Hee Lee, Keon Wook Kang and June-Key Chung

PDF  |  HTML  |  Supplementary Files  |  How to cite  |  Order a Reprint

Oncotarget. 2017; 8:9899-9910. https://doi.org/10.18632/oncotarget.14247

Metrics: PDF 4029 views  |   HTML 3317 views  |   ?  


Abstract

Kyung Oh Jung1,2,3,5, Hyewon Youn1,3,4, Chul-Hee Lee1,2,3, Keon Wook Kang1,3, June-Key Chung1,2,3

1Department of Nuclear Medicine, Seoul National University College of Medicine, Seoul, Korea, 110-799

2Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Korea, 110-799

3Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea, 110-799

4Cancer Imaging Center, Seoul National University Hospital, Seoul, Korea, 110-799

5Current affiliation: Department of Radiation Oncology & Medical Physics, Stanford University, CA, USA, 94305

Correspondence to:

Hyewon Youn, email: hwyoun@snu.ac.kr

June-key Chung, email: jkchung@snu.ac.kr

Keywords: exosome, breast cancer, miR-210, tumor microenvironment, hypoxia

Received: August 01, 2016     Accepted: December 01, 2016     Published: December 27, 2016

ABSTRACT

Cancer cells actively release exosomes carrying specific cellular components, such as proteins, mRNA, and miRNA, to communicate with various cells in the tumor microenvironment. We visualized exosome-mediated transfer of miR-210 from hypoxic breast cancer cells to neighboring cells using a miR-210 specific reporter system. By in vitro and in vivo visualization, we found that exosomes with miR-210 were transferred to cells in the tumor microenvironment and that miR-210 was involved in expression of vascular remodeling related genes, such as Ephrin A3 and PTP1B, to promote angiogenesis. These results indicate that cellular components, such as miRNAs from hypoxic cancer cells, spread to adjacent cancer cells in the tumor microenvironment via exosomes and influence tumor progression.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 14247